JP2022553954A5 - - Google Patents
Info
- Publication number
- JP2022553954A5 JP2022553954A5 JP2022523564A JP2022523564A JP2022553954A5 JP 2022553954 A5 JP2022553954 A5 JP 2022553954A5 JP 2022523564 A JP2022523564 A JP 2022523564A JP 2022523564 A JP2022523564 A JP 2022523564A JP 2022553954 A5 JP2022553954 A5 JP 2022553954A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- formula
- therapeutically effective
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025120941A JP2025157436A (ja) | 2019-10-22 | 2025-07-18 | 前立腺癌を治療する方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962924655P | 2019-10-22 | 2019-10-22 | |
| US62/924,655 | 2019-10-22 | ||
| US201962945418P | 2019-12-09 | 2019-12-09 | |
| US62/945,418 | 2019-12-09 | ||
| US202063028843P | 2020-05-22 | 2020-05-22 | |
| US63/028,843 | 2020-05-22 | ||
| US202063032453P | 2020-05-29 | 2020-05-29 | |
| US63/032,453 | 2020-05-29 | ||
| PCT/US2020/056684 WO2021081108A1 (en) | 2019-10-22 | 2020-10-21 | Methods of treating prostate cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120941A Division JP2025157436A (ja) | 2019-10-22 | 2025-07-18 | 前立腺癌を治療する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553954A JP2022553954A (ja) | 2022-12-27 |
| JP2022553954A5 true JP2022553954A5 (https=) | 2023-10-20 |
| JP7716396B2 JP7716396B2 (ja) | 2025-07-31 |
Family
ID=73449188
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523564A Active JP7716396B2 (ja) | 2019-10-22 | 2020-10-21 | 前立腺癌を治療する方法 |
| JP2025120941A Pending JP2025157436A (ja) | 2019-10-22 | 2025-07-18 | 前立腺癌を治療する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120941A Pending JP2025157436A (ja) | 2019-10-22 | 2025-07-18 | 前立腺癌を治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20210113557A1 (https=) |
| EP (1) | EP4048236A1 (https=) |
| JP (2) | JP7716396B2 (https=) |
| KR (1) | KR20220087482A (https=) |
| CN (1) | CN115135313A (https=) |
| AU (1) | AU2020370150A1 (https=) |
| CA (1) | CA3158411A1 (https=) |
| IL (1) | IL292359A (https=) |
| MX (1) | MX2022004808A (https=) |
| WO (1) | WO2021081108A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180228907A1 (en) | 2014-04-14 | 2018-08-16 | Arvinas, Inc. | Cereblon ligands and bifunctional compounds comprising the same |
| CN110506039A (zh) | 2016-10-11 | 2019-11-26 | 阿尔维纳斯股份有限公司 | 用于雄激素受体靶向降解的化合物和方法 |
| CR20220630A (es) | 2020-05-09 | 2023-01-23 | Arvinas Operations Inc | Métodos para fabricar un compuesto bifuncional, formas ultrapuras del compuesto bifuncional y formas de dosificación que comprenden el mismo |
| WO2022048605A1 (zh) * | 2020-09-04 | 2022-03-10 | 南昌奥瑞药业有限公司 | 一种杂环化合物、其制备方法、中间体、组合物以及应用 |
| JP2023547084A (ja) * | 2020-10-21 | 2023-11-09 | アルビナス・オペレーションズ・インコーポレイテッド | アンドロゲン受容体タンパク質の標的分解のための化合物および方法 |
| JP2023552818A (ja) * | 2020-12-11 | 2023-12-19 | アルビナス・オペレーションズ・インコーポレイテッド | 前立腺癌を治療する方法 |
| CN113620931B (zh) * | 2021-09-13 | 2023-06-09 | 中国海洋大学 | 一种雄激素受体抑制剂及其用途 |
| US20250248999A1 (en) * | 2022-04-21 | 2025-08-07 | Arvinas Operations, Inc. | Bavdegalutamide and combinations thereof for use in treating prostate cancer |
| WO2024233696A1 (en) * | 2023-05-09 | 2024-11-14 | Arvinas Operations, Inc. | Bavdegalutamide for treating prostate cancer without ar l702h mutation |
| TW202535392A (zh) | 2023-12-08 | 2025-09-16 | 美商亞文納營運公司 | 使用雄性素受體降解劑治療脊髓延髓性肌肉萎縮 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US20140255413A1 (en) * | 2013-03-07 | 2014-09-11 | Boehringer Ingelheim International Gmbh | Combination therapy for neoplasia treatment |
| US20140287039A1 (en) * | 2013-03-15 | 2014-09-25 | Iceutica Inc. | Abiraterone Acetate Formulation |
| WO2015114314A1 (en) * | 2014-01-28 | 2015-08-06 | Cipla Limited | Pharmaceutical composition comprising abiraterone |
| RU2738833C9 (ru) * | 2014-04-14 | 2022-02-28 | Арвинас, Оперэйшнз, Инк. | Имидные модуляторы протеолиза и способы их применения |
| WO2016081472A1 (en) * | 2014-11-21 | 2016-05-26 | Biohaven Pharmaceutical Holding Company Ltd. | Sublingual formulation of riluzole |
| CN109310664A (zh) * | 2016-06-10 | 2019-02-05 | 田纳西大学研究基金会 | 选择性雄激素受体降解剂(sard)配体和其使用方法 |
| JOP20190067A1 (ar) * | 2016-09-30 | 2019-03-28 | Janssen Pharmaceutica Nv | طُرق تشخيص وعلاج سرطان البروستاتا النقيلي المقاوم للإخصاء والمقاوم أو الحساس لأبيراتيرون أسيتات-الهرمون القشري السكري |
| CN110506039A (zh) * | 2016-10-11 | 2019-11-26 | 阿尔维纳斯股份有限公司 | 用于雄激素受体靶向降解的化合物和方法 |
-
2020
- 2020-10-21 KR KR1020227016404A patent/KR20220087482A/ko not_active Ceased
- 2020-10-21 MX MX2022004808A patent/MX2022004808A/es unknown
- 2020-10-21 CA CA3158411A patent/CA3158411A1/en active Pending
- 2020-10-21 CN CN202080080511.2A patent/CN115135313A/zh active Pending
- 2020-10-21 WO PCT/US2020/056684 patent/WO2021081108A1/en not_active Ceased
- 2020-10-21 IL IL292359A patent/IL292359A/en unknown
- 2020-10-21 AU AU2020370150A patent/AU2020370150A1/en active Pending
- 2020-10-21 US US17/075,808 patent/US20210113557A1/en not_active Abandoned
- 2020-10-21 EP EP20807571.3A patent/EP4048236A1/en not_active Withdrawn
- 2020-10-21 JP JP2022523564A patent/JP7716396B2/ja active Active
-
2022
- 2022-12-21 US US18/085,869 patent/US20230128132A1/en not_active Abandoned
-
2025
- 2025-07-18 JP JP2025120941A patent/JP2025157436A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022553954A5 (https=) | ||
| JP2022546471A5 (https=) | ||
| TWI800914B (zh) | Fxr激動劑之固體形式 | |
| JP2025116875A5 (https=) | ||
| IL178745A (en) | Use of 4- (amino) -2 (2, 6-dioxo (3-piperidyl)) -isoindoline -1, 3-discussion of preparation of a medical vaccine for the treatment of myeloma | |
| US12077554B2 (en) | CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer | |
| KR20070014184A (ko) | 성기능 장애 치료용 신규 약제학적 조성물 ⅱ | |
| JP2019515884A5 (https=) | ||
| JP2024520630A5 (https=) | ||
| JP2017530175A5 (https=) | ||
| JP2010540508A5 (https=) | ||
| JP2022544711A5 (https=) | ||
| US11065240B2 (en) | Drug combinations to treat multiple myeloma | |
| JP2016534063A5 (https=) | ||
| JP2020533283A5 (https=) | ||
| CN106999462A (zh) | 包含选择性s1p1受体激动剂的药物组合物 | |
| JP2024531188A5 (https=) | ||
| JP2021534160A5 (https=) | ||
| EP2124930B1 (en) | Isosorbide mononitrate derivatives for the treatment of intestinal disorders | |
| JP2025118775A5 (https=) | ||
| JP7854206B2 (ja) | 肺線維症の予防または治療用の薬学製剤 | |
| JP2022518288A5 (https=) | ||
| EP1345610B1 (en) | Quetiapine for treating of dyskinesia in non-psychotic patients | |
| JP7788550B2 (ja) | ターフェニル化合物の安息香酸塩の製造方法 | |
| EP0623346A1 (en) | Inhibitor for metastasis of malignant tumor |